Pharma & Biotech
VT De Lisle America Fund's objective is to invest in a range of stocks that Wall Street either misses or ignores and to provide better investment returns than the S&P 500.
The fund invests in US small-cap value with a portfolio of 90-130 stocks.
© Proactive 2021.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.